NeoPharm Co (XKRX:092730) Total Stockholders Equity : ₩174,633 Mil (As of Mar. 2025)

View and export this data going back to 2007. Start your Free Trial

What is NeoPharm Co Total Stockholders Equity?

NeoPharm Co's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ₩174,633 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. NeoPharm Co's Book Value per Share for the quarter that ended in Mar. 2025 was ₩11,165.05. The ratio of a company's debt over equity can be used to measure how leveraged this company is. NeoPharm Co's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.00.

NeoPharm Co Total Stockholders Equity Historical Data

The historical data trend for NeoPharm Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeoPharm Co Total Stockholders Equity Chart

NeoPharm Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

117,717.55

130,304.93

142,210.81

160,025.95

176,884.84

NeoPharm Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															160,252.65	166,084.19	170,506.70	176,884.84	174,632.56

NeoPharm Co (XKRX:092730) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

NeoPharm Co's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(174632.564	-	0)	/	15.641
	=	11,165.05

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

NeoPharm Co's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(348.097	+	119.586)	/	174632.564
	=	0.00

NeoPharm Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of NeoPharm Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

NeoPharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » NeoPharm Co Ltd (XKRX:092730) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

928 Tamnip-dong, Yuseong-gu, Daejon, KOR, 305-510

Website

http://www.neopharm.co.kr

NeoPharm Co Ltd is a South Korean company operating in the household and personal products. The products of the company include skin care brand, skin barrier special dermo cosmetic brand, hospital functional products, and life moisturizing body professional brand.

NeoPharm Co Headlines

No Headlines